Rockaway, NJ, United States of America

Jiwaji Gulabrao Suryawanshi


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiwaji Gulabrao Suryawanshi: Innovator in Pharmaceutical Compositions

Introduction

Jiwaji Gulabrao Suryawanshi, an accomplished inventor based in Rockaway, NJ, has made significant contributions to the field of pharmaceuticals. With a pivotal focus on estrogenic agents, his innovative work has been recognized through a patented invention that holds promise for medical applications.

Latest Patents

Suryawanshi is credited with a patent involving pharmaceutical compositions of estrogenic agents. His inventive work relates to novel pharmaceutical carrier systems and oral compositions that include substances such as 1-[4-(2-Azepan-1yl-ethoxy)-benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol and 2-(4-Hydroxy-phenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)benzyl]-1H-indol-5-ol, along with their pharmaceutically acceptable salts. This invention could potentially pave the way for new therapeutic approaches in hormone-related treatments.

Career Highlights

Suryawanshi has built his career at Wyeth, a leading pharmaceutical company known for its innovative healthcare solutions. His work at this prestigious firm highlights his dedication to advancing the field of medicine through research and development of novel pharmaceutical compositions.

Collaborations

Throughout his career, Suryawanshi has had the opportunity to collaborate with talented colleagues, including Eric Joel Benjamin and Wendy Ann Dulin. These collaborations have undoubtedly enriched his research endeavors and contributed to the development of effective pharmaceutical solutions.

Conclusion

Jiwaji Gulabrao Suryawanshi stands out as a notable inventor with a patented innovation that enhances our understanding of pharmaceutical compositions involving estrogenic agents. His contributions at Wyeth and collaboration with esteemed colleagues continue to inspire advancements in the pharmaceutical industry, emphasizing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…